RETRACTION: Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin Attenuates Sorafenib-Induced Myocardial Inflammation and Toxicity

Abstract

C.-H. Liu, Y.-C. Ho, W.-C. Lee, C.-Y. Huang, Y.-K. Lee, C.-B. Hsieh, N.-C. Huang, C.-C. Wu, N. U. N. Nguyen, C.-C. Hsu, C.-H. Chen, Y.-C. Chen, W.-C. Huang, Y.-Y. Lu, C.-C. Fang, Y.-C. Chang, C.-L. Chang, M.-K. Tsai, Z.-H. Wen, C.-Z. Li, C.-C. Li, P.-K. Chuang, S.-M. Yang, T.-H. Chu, and S.-C. Huang, "Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin Attenuates Sorafenib-Induced Myocardial Inflammation and Toxicity," Environmental Toxicology 39, no. 11 (2024): 4844-4858, https://doi.org/10.1002/tox.24362. The above article, published online on 17 June 2024 in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor-in-Chief, April Rodd; and Wiley Periodicals LLC. Following an investigation by the publisher, the parties have concluded that this article was accepted solely on the basis of a compromised peer review process. Therefore, the article must be retracted. Authors Z.-H. Wen, T.-H. Chu and S.-C. Huang disagree with the retraction. Authors C.-H. Liu, Y.-C. Ho, W.-C. Lee, C.-Y. Huang, Y.-K. Lee, C.-B. Hsieh, N.-C. Huang, C.-C. Wu, C.-C. Hsu, Y.-C. Chen, W.-C. Huang, Y.-Y. Lu, C.-C. Fang, Y.-C. Chang, C.-L. Chang, M.-K. Tsai, C.-Z. Li, C.-C. Li, P.-K. Chuang and S.-M. Yang did not respond to communications from the Publisher regarding the retraction. Authors N. U. N. Nguyen and C.-H. Chen could not be reached for comment regarding the retraction.